CD274 and non-small cell lung carcinoma: For evaluation of the PD-L1 TPS in NSCLC tissue samples, the FDA approved a validation assay from Dako/Agilent for qualitative assessment of PD-L1 protein expression in formalin-fixed paraffin-embedded (FFPE) tissue samples of NSCLC patients.